IL-1 (TIR domain)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2616b/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2616b/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2616a/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2616a/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26169/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26169/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26168/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26168/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26167/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26167/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26166/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26166/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26165/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26165/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26164/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26164/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26163/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26163/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26162/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26162/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26161/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26161/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26160/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26160/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2615f/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2615f/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2615e/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2615e/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2615d/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2615d/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2615c/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2615c/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2615b/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2615b/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2615a/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2615a/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26159/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26159/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26158/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26158/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26157/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26157/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26156/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26156/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26155/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26155/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26154/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26154/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26153/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26153/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26152/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26152/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26151/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26151/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26150/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26150/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2614f/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2614f/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2614e/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2614e/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2614d/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2614d/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2614c/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2614c/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2614b/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2614b/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e2614a/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e2614a/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26149/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26149/il-1-tir-domain.png"},{"image":"https://icons.biorender.com/w75xh75/5fda4ed52c7b720026e26148/il-1-tir-domain.png","waterMarkImage":"https://icons.biorender.com/w550xh620/5fda4ed52c7b720026e26148/il-1-tir-domain.png"}]
Keywords
TIR domain,TIR,interleukin-1 receptor accessory protein,interleukin,interleukin 1,IL,Il-1,IL-1,IL-1 receptor 1,interleukin receptor,interleukin 1 receptor type 1,IL1R1,IL1RAP,IL-1RAP,IL-1R1 IL-1RAP complex,TIR